Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI]

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI]
Treatment and conditionWhere it standsTrials
Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI] for endometrial neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1